Rapamycin: the most-studied mTOR inhibitor in aging research.
Rapamycin (sirolimus) is FDA-approved for transplant rejection. Off-label use for longevity is an active area of research, including the PEARL human trial. Pepvio’s protocol is prescribed and monitored by licensed physicians.
2 minutes · No commitment · $299/mo if approved
Researching rapamycin for longevity after reading the clinical literature
Looking for a physician-supervised off-label protocol
Evaluating mTOR inhibition as part of a longevity stack
Interested in the PEARL trial data and its implications
Inhibits mTOR — a central regulator of cell growth, autophagy, and protein synthesis studied extensively in aging research
Pulsed dosing schedule based on published longevity research protocols
Quarterly bloodwork and physician monitoring included
Eligibility, dosing, and contraindication screening determined during intake
What's in this protocol
Rapamycin
5-10mg once weekly, oral capsule (under physician supervision)
Sirolimus — an FDA-approved molecule used off-label for longevity. The most-studied mTOR inhibitor in the healthspan research, extending median lifespan in every mammal tested.
Flexible payment options available at checkout · Cancel anytime
Ready to start?
Take a free 2-minute assessment. If a licensed provider approves your protocol, your medication ships directly to your door. Not approved? Your card is never charged.
Start Free AssessmentThese statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. All prescription medications require a valid prescription from a licensed healthcare provider.